Nivolumab, is a targeted therapy drug used in cancer treatment. Here are the key points:

Purpose and Mechanism:
- Nivolumab is an immune checkpoint inhibitor that binds to the protein PD-1 on immune cells called T cells.
- It helps prevent cancer cells from suppressing the immune system, allowing the immune system to fight cancer more effectively.
Administration:
- Nivolumab is given as an intravenous infusion (IV) in a hospital or clinic.
- The infusion takes 30 to 90 minutes and is usually given once every 2 to 4 weeks.
- Depending on your specific cancer type and treatment plan, it may be combined with other medications like ipilimumab or chemotherapy.
Indications:
- Nivolumab is used to treat various cancers, including melanoma, non-small cell lung cancer, renal cell cancer, Hodgkin’s lymphoma, head and neck cancer, colorectal cancer, hepatocellular carcinoma, esophageal cancer, gastric cancer, and malignant pleural mesothelioma.

Remember to consult your healthcare provider for personalized advice. If you have further questions, feel free to ask! 😊

Nivolumab

Strengths
10 mg/ml 4ml
Container
Glass Vial
Use
Nivolumab is used to treat various cancers, including melanoma, non-small cell lung cancer, renal cell cancer, Hodgkin’s lymphoma, head and neck cancer, colorectal cancer, hepatocellular carcinoma, esophageal cancer, gastric cancer, and malignant pleural mesothelioma.
Targate
PD-1

Strengths